LALPATHLAB — Dr. Lal PathLabs Balance Sheet
0.000.00%
- IN₹259.37bn
- IN₹249.12bn
- IN₹24.61bn
- 100
- 9
- 98
- 82
Annual balance sheet for Dr. Lal PathLabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | C2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 9,840 | 6,817 | 8,143 | 9,426 | 11,641 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 927 | 1,083 | 953 | 1,119 | 1,259 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11,452 | 8,752 | 9,731 | 11,267 | 13,635 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,120 | 4,298 | 4,040 | 3,470 | 3,393 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 16,613 | 23,468 | 23,856 | 24,560 | 27,168 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,743 | 5,000 | 4,698 | 4,636 | 4,024 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 4,163 | 8,451 | 7,193 | 6,067 | 5,441 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 12,451 | 15,016 | 16,663 | 18,493 | 21,727 |
| Total Liabilities & Shareholders' Equity | 16,613 | 23,468 | 23,856 | 24,560 | 27,168 |
| Total Common Shares Outstanding |